Skip to main content

Table 3 Treatment pathways by route of administration

From: Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosis

  DMT-treated patients First Treatment Course
Oral Injectable Infusion
Second DMT treatment course
 n 7510   541   6898   71  
Route of administration (n, %)
 Oral 2247 29.9 423 78.2 1799 26.1 25 35.2
 Injectable 5119 68.2 106 19.6 4993 72.4 20 28.2
 Infusion 144 1.9 12 2.2 106 1.5 26 36.6
Restart first DMT (n, %) 3843 51.2 268 49.5 3555 51.5 20 28.2
Third DMT treatment course
 n 3882   200   3645   37  
Route of administration (n, %)
 Oral 1234 31.8 149 74.5 1067 29.3 18 48.6
 Injectable 2587 66.6 47 23.5 2530 69.4 10 27.0
 Infusion 61 1.6 4 2.0 48 1.3 9 24.3
Restart second DMT (n, %) 2325 59.9 115 57.5 2194 60.2 16 43.2